NCT05902988: A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 200 planned
- Started
- 18 Oct 2023
- Primary completion
- Jun 2026
- Arms
- Dose Escalation: Dose Escalation Cohorts, Dose Escalation: Backfill Cohorts, Dose Expansion: Exploration Cohorts, Dose Expansion: Development Cohorts
- Results
- None posted
- 15 Jun 2023: Trial registered
- 18 Oct 2023: Trial started